Description
Simulect Injection 20 mg – Basiliximab for Kidney Transplant Rejection Prevention
When your body receives a new kidney, your immune system treats that organ as a foreign threat. Without proper immunosuppressive therapy, the body launches an aggressive response that can destroy the transplanted organ within days. Simulect Injection 20 mg steps in at a critical point in that process, suppressing the exact immune pathway responsible for acute rejection before it causes irreversible damage.
At Ahmad Medico, you get access to Simulect Injection at a competitive price in Pakistan, backed by fast delivery and verified product sourcing.
What Is Simulect Injection?
Simulect Injection contains basiliximab, a chimeric (murine/human) monoclonal antibody developed by Novartis Pharma AG. It belongs to the class of interleukin-2 (IL-2) receptor antagonists. Basiliximab works by binding specifically to the CD25 antigen, the alpha chain of the IL-2 receptor, on the surface of activated T-lymphocytes. By occupying this receptor, it blocks the IL-2 signal that would otherwise trigger rapid T-cell proliferation, which is the core mechanism behind acute transplant rejection.
In simpler terms, your immune system needs IL-2 to mobilize the T-cells that attack a new organ. Simulect blocks that signal at their source. The result is a targeted reduction in rejection risk without the broad immunosuppression that older agents cause.
Simulect Injection Uses
The primary and approved use of Simulect is the prophylaxis (prevention) of acute organ rejection in adult and pediatric patients who receive kidney transplants. Transplant physicians use it as part of a triple immunosuppression regimen that typically includes:
- Cyclosporine microemulsion (calcineurin inhibitor)
- Corticosteroids (e.g., methylprednisolone or prednisone)
- With or without mycophenolate mofetil or azathioprine
Simulect does not replace the other immunosuppressants; it works alongside them during the highest-risk period right after transplantation. Clinical trials have consistently demonstrated that adding Simulect to standard therapy significantly reduces the rate of acute rejection episodes in the first six to twelve months post-transplant.
Dosing and Administration
Simulect Injection 20 mg follows a two-dose protocol in adults:
- First dose: 20 mg administered intravenously within two hours before the transplant surgery
- Second dose: 20 mg administered intravenously on Day 4 after transplantation
Each 20 mg vial is reconstituted with 5 mL of sterile water for injection and then further diluted with 50 mL of 0.9% sodium chloride or 5% dextrose solution. It is given either as an intravenous bolus injection or as a slow IV infusion over 20 to 30 minutes.
For pediatric patients weighing less than 35 kg, the dose is reduced to 10 mg per injection. Patients weighing 35 kg or more receive the standard adult dose.
This medication is administered by a transplant physician or trained clinical staff in a hospital setting. It is not a self-administered drug.
Is a Prescription Required for Simulect?
Yes. Simulect Injection is a prescription-only medicine. No pharmacy, online or offline, should dispense it without a valid prescription from a licensed transplant specialist or physician. At Ahmad Medico, we follow all regulatory guidelines. When you place your order, our pharmacy team verifies your prescription before processing.
Simulect Side Effects
Like all immunosuppressive medicines, Simulect carries a risk of side effects. Most of those reported in clinical studies occurred in patients on multiple immunosuppressants simultaneously, which makes it difficult to attribute specific effects to Simulect alone. However, based on clinical data, the following are documented:
Common side effects:
- Peripheral edema (swelling in the limbs)
- Constipation and gastrointestinal disturbances
- Urinary tract infections
- Hypertension (high blood pressure)
- Anemia
- Fever and headache
- Hypokalemia (low potassium levels)
- Hyperglycemia (raised blood sugar)
- Elevated cholesterol and uric acid levels
Serious but less common:
- Severe hypersensitivity or anaphylactic reactions, particularly on re-exposure to basiliximab in subsequent transplants
- Cytokine release syndrome (rare)
If you notice signs of an allergic reaction, such as difficulty breathing, chest tightness, rash, or a sudden drop in blood pressure during administration, report it to medical staff immediately.
Simulect is not recommended during pregnancy or breastfeeding unless the benefit clearly outweighs the risk. Women of childbearing age should use effective contraception during treatment and for up to four months after the second dose.
Why Simulect Works Where Other Agents Fall Short
Older immunosuppressants work by broadly suppressing your immune system. While effective, that approach raises infection risk and creates long-term metabolic complications. Basiliximab, by contrast, targets a very specific step in the T-cell activation pathway. It reduces the rejection response without completely disabling immune function. That precision is why transplant medicine has moved toward targeted biologics like Simulect as part of induction therapy.
Simulect Injection Price in Pakistan
The price of Simulect Injection 20 mg in Pakistan reflects its status as a specialist biologic therapy. At Ahmad Medico, we work to offer it at the most competitive rate as PKR 90,000, with the assurance that every product we stock comes from verified, authentic supply chains. For the current Simulect Injection price in Pakistan, check the listed price on this page or contact our team directly.
Order Simulect Injection from Ahmad Medico
Ahmad Medico is Pakistan’s trusted online pharmacy for specialist and prescription medicines. When you order Simulect Injection through our platform, you get verified product quality, prescription verification, and reliable delivery, so critical medications reach you when and where you need them.
